Helen Mearns

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

Albanus O. Moguche, Munyaradzi Musvosvi, Adam Penn‐Nicholson et al. · Cell Host & Microbe · 2017 · 180 citations · Full text

Pulmonary Tuberculosis, Adaptive Immune System, T-regulatory Cell +8

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Vaccination, Vaccine Safety, Pulmonary Tuberculosis +7

Delayed Goblet Cell Hyperplasia, Acetylcholine Receptor Expression, and Worm Expulsion in SMC-Specific IL-4Rα–Deficient Mice

William Horsnell, Antony J. Cutler, J. Claire Hoving et al. · PLoS Pathogens · 2007 · 91 citations · Full text

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

Hennie Geldenhuys, Helen Mearns, David J. C. Miles et al. · Vaccine · 2015 · 79 citations

Vaccination, Immunology, Vaccine Trial +8

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

Helen Mearns, Hennie Geldenhuys, Benjamin M. Kagina et al. · Vaccine · 2016 · 40 citations

Vaccination, Vaccinology, M. Tuberculosis +10